Hara, C.; Suzue, M.; Fujimoto, S.; Fukushima, Y.; Sayanagi, K.; Nishida, K.; Maruyama, K.; Sato, S.; Nishida, K.
Comparison of Loading Dose between Aflibercept and Faricimab for Neovascular Age-Related Macular Degeneration. J. Clin. Med. 2024, 13, 385.
https://doi.org/10.3390/jcm13020385
AMA Style
Hara C, Suzue M, Fujimoto S, Fukushima Y, Sayanagi K, Nishida K, Maruyama K, Sato S, Nishida K.
Comparison of Loading Dose between Aflibercept and Faricimab for Neovascular Age-Related Macular Degeneration. Journal of Clinical Medicine. 2024; 13(2):385.
https://doi.org/10.3390/jcm13020385
Chicago/Turabian Style
Hara, Chikako, Masaki Suzue, Satoko Fujimoto, Yoko Fukushima, Kaori Sayanagi, Kentaro Nishida, Kazuichi Maruyama, Shigeru Sato, and Kohji Nishida.
2024. "Comparison of Loading Dose between Aflibercept and Faricimab for Neovascular Age-Related Macular Degeneration" Journal of Clinical Medicine 13, no. 2: 385.
https://doi.org/10.3390/jcm13020385
APA Style
Hara, C., Suzue, M., Fujimoto, S., Fukushima, Y., Sayanagi, K., Nishida, K., Maruyama, K., Sato, S., & Nishida, K.
(2024). Comparison of Loading Dose between Aflibercept and Faricimab for Neovascular Age-Related Macular Degeneration. Journal of Clinical Medicine, 13(2), 385.
https://doi.org/10.3390/jcm13020385
